1. Home
  2. BCRX vs VVX Comparison

BCRX vs VVX Comparison

Compare BCRX & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • VVX
  • Stock Information
  • Founded
  • BCRX 1986
  • VVX 2014
  • Country
  • BCRX United States
  • VVX United States
  • Employees
  • BCRX N/A
  • VVX N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • VVX Diversified Commercial Services
  • Sector
  • BCRX Health Care
  • VVX Consumer Discretionary
  • Exchange
  • BCRX Nasdaq
  • VVX Nasdaq
  • Market Cap
  • BCRX 1.9B
  • VVX 1.6B
  • IPO Year
  • BCRX 1994
  • VVX 2014
  • Fundamental
  • Price
  • BCRX $8.66
  • VVX $48.23
  • Analyst Decision
  • BCRX Strong Buy
  • VVX Buy
  • Analyst Count
  • BCRX 10
  • VVX 9
  • Target Price
  • BCRX $16.70
  • VVX $64.11
  • AVG Volume (30 Days)
  • BCRX 3.2M
  • VVX 222.4K
  • Earning Date
  • BCRX 08-04-2025
  • VVX 08-04-2025
  • Dividend Yield
  • BCRX N/A
  • VVX N/A
  • EPS Growth
  • BCRX N/A
  • VVX N/A
  • EPS
  • BCRX N/A
  • VVX 1.29
  • Revenue
  • BCRX $503,485,000.00
  • VVX $4,327,514,000.00
  • Revenue This Year
  • BCRX $38.50
  • VVX $4.09
  • Revenue Next Year
  • BCRX $10.04
  • VVX $4.91
  • P/E Ratio
  • BCRX N/A
  • VVX $36.68
  • Revenue Growth
  • BCRX 41.67
  • VVX 7.38
  • 52 Week Low
  • BCRX $6.02
  • VVX $41.08
  • 52 Week High
  • BCRX $11.31
  • VVX $69.75
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 35.06
  • VVX 46.34
  • Support Level
  • BCRX $8.40
  • VVX $46.69
  • Resistance Level
  • BCRX $8.79
  • VVX $48.28
  • Average True Range (ATR)
  • BCRX 0.25
  • VVX 1.23
  • MACD
  • BCRX -0.00
  • VVX -0.25
  • Stochastic Oscillator
  • BCRX 18.07
  • VVX 23.49

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

Share on Social Networks: